Viridans streptococcal bacteraemia: a clinical survey.
The occurrence of viridans streptococcal bacteraemia (VSB) in a London postgraduate teaching hospital was analysed retrospectively. Over a 30-month period, 39 patients with VSB were identified, and the clinical significance of VSB was assessed for each, based upon clinical and laboratory information. Endocarditis accounted for only 13% of the total patients with apparent VSB. A greater proportion of patients with VSB originated from the haematology unit (21%) and in particular, the bone-marrow transplantation unit (15%). VSB also occurred in patients with solid epithelial malignancies and in children aged < 12 months. Mortality associated with VSB was 7%. Viridans streptococci are emerging as important pathogens in previously unrecognized clinical settings, particularly hospitalized, immunocompromised patients.